Nuclear factor-κB activation is not involved in a MPTP model of Parkinson's disease

Peter Teismann, Markus Schwaninger, Falk Weih, Boris Ferger*

*Corresponding author for this work
33 Citations (Scopus)


In the present study the involvement of hydroxyl free radicals and nuclear factor-κB (NF-κB) activation was investigated in the MPTP (I-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) model of Parkinson's disease. MPTP (30mg/kg, s.c.) produced a significant 2-fold increase in hydroxyl free radicals in the striatum of C57BL/6 mice determined by microdialysis in combination with the salicylate hydroxylation assay. Electrophoretic mobility shift assays did not detect NF-κB activation after MPTP treatment. Furthermore, p50-deficient mice showed only minor differences in striatal dopamine and metabolite levels as well as tyrosine hydroxylase immunoreactivity after MPTP administration in comparison to wildtype mice. We postulate that, although hydroxyl radical production was enhanced, NF-κB plays only a minor role in the MPTP model because neither neurochemical nor immunocytochemical parameters were altered in p50-deficient mice in comparison to controls.

Original languageEnglish
Issue number5
Pages (from-to)1049-1053
Number of pages5
Publication statusPublished - 17.04.2001

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)


Dive into the research topics of 'Nuclear factor-κB activation is not involved in a MPTP model of Parkinson's disease'. Together they form a unique fingerprint.

Cite this